| HIV therapy by a combination of broadly neutralizing antibodies in humanized mice F Klein, A Halper-Stromberg, JA Horwitz, H Gruell, JF Scheid, ... Nature 492 (7427), 118-122, 2012 | 582 | 2012 |
| Type I and type II Fc receptors regulate innate and adaptive immunity A Pincetic, S Bournazos, DJ DiLillo, J Maamary, TT Wang, R Dahan, ... Nature immunology 15 (8), 707-716, 2014 | 547 | 2014 |
| Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity S Bournazos, F Klein, J Pietzsch, MS Seaman, MC Nussenzweig, ... Cell 158 (6), 1243-1253, 2014 | 516 | 2014 |
| The role of IgG Fc receptors in antibody-dependent enhancement S Bournazos, A Gupta, JV Ravetch Nature Reviews Immunology 20 (10), 633-643, 2020 | 433 | 2020 |
| Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice A Halper-Stromberg, CL Lu, F Klein, JA Horwitz, S Bournazos, L Nogueira, ... Cell 158 (5), 989-999, 2014 | 423 | 2014 |
| Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo CL Lu, DK Murakowski, S Bournazos, T Schoofs, D Sarkar, ... Science 352 (6288), 1001-1004, 2016 | 364 | 2016 |
| IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity TT Wang, J Sewatanon, MJ Memoli, J Wrammert, S Bournazos, ... Science 355 (6323), 395-398, 2017 | 351 | 2017 |
| Modulating IgG effector function by Fc glycan engineering T Li, DJ DiLillo, S Bournazos, JP Giddens, JV Ravetch, LX Wang Proceedings of the National Academy of Sciences 114 (13), 3485-3490, 2017 | 336 | 2017 |
| Fc receptors JV Ravetch, S Bournazos Molecular Biology of B Cells, 129-140, 2024 | 334 | 2024 |
| Mouse model recapitulating human Fcγ receptor structural and functional diversity P Smith, DJ DiLillo, S Bournazos, F Li, JV Ravetch Proceedings of the National Academy of Sciences 109 (16), 6181-6186, 2012 | 333 | 2012 |
| Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... Journal of Experimental Medicine 218 (3), e20201993, 2020 | 313 | 2020 |
| Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin I Bournazou, JD Pound, R Duffin, S Bournazos, LA Melville, SB Brown, ... The Journal of clinical investigation 119 (1), 20-32, 2009 | 296 | 2009 |
| Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy TT Wang, J Maamary, GS Tan, S Bournazos, CW Davis, F Krammer, ... Cell 162 (1), 160-169, 2015 | 214 | 2015 |
| Signaling by antibodies: recent progress S Bournazos, TT Wang, R Dahan, J Maamary, JV Ravetch Annual review of immunology 35, 285-311, 2017 | 208 | 2017 |
| Functional and clinical consequences of Fc receptor polymorphic and copy number variants S Bournazos, JM Woof, SP Hart, I Dransfield Clinical & Experimental Immunology 157 (2), 244-254, 2009 | 201 | 2009 |
| Fcγ receptor function and the design of vaccination strategies S Bournazos, JV Ravetch Immunity 47 (2), 224-233, 2017 | 182 | 2017 |
| The role of Fc–FcγR interactions in IgG-mediated microbial neutralization S Bournazos, DJ DiLillo, JV Ravetch Journal of Experimental Medicine 212 (9), 1361-1369, 2015 | 168 | 2015 |
| The role and function of Fcγ receptors on myeloid cells S Bournazos, TT Wang, JV Ravetch Microbiology spectrum 4 (6), 4.6. 20, 2016 | 160 | 2016 |
| Bispecific anti-HIV-1 antibodies with enhanced breadth and potency S Bournazos, A Gazumyan, MS Seaman, MC Nussenzweig, JV Ravetch Cell 165 (7), 1609-1620, 2016 | 156 | 2016 |
| Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages A McColl, S Bournazos, S Franz, M Perretti, BP Morgan, C Haslett, ... The Journal of Immunology 183 (3), 2167-2175, 2009 | 155 | 2009 |
